Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 14, 2025
InVivo Biosystems Advances AI Technology for Real Time Animal Health Monitoring
EIN Presswire
·
April 14, 2025
InVivo Biosystems announces acquisition of SBIR Phase II funding for AI-Powered Animal Health Monitoring Technology EUGENE, OR, UNITED STATES, April 13, 2025 /EINPresswire.com/ -- InVivo Biosystems, a leader in zebrafish research solutions, is proud to …
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
GlobeNewswire
·
April 14, 2025
FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare …
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers
GlobeNewswire
·
April 14, 2025
NAPLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology innovation, is proud to announce the appointment of Anthony "Tony" Scuilla as a strategic sales consultant. In his new role, Mr. …
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
GlobeNewswire
·
April 14, 2025
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical safety and activity data from ongoing …
Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line
GlobeNewswire
·
April 14, 2025
Fort Mill, S.C., April 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has …
SBC Medical Group Holdings, Inc. Purchases 5 BTC
GlobeNewswire
·
April 14, 2025
IRVINE,Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcement of a decision to purchase Bitcoin (BTC) disclosed on February 12, 2025, it …
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
GlobeNewswire
·
April 14, 2025
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
Elutia Confirms No Material Impact from Global Tariffs
GlobeNewswire
·
April 14, 2025
SILVER SPRING, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today confirmed that the ongoing global tariff environment has had no material impact on its …
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
GlobeNewswire
·
April 14, 2025
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and …
Soleno Therapeutics Announces VYKAT(TM) XR Launch
GlobeNewswire
·
April 14, 2025
REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the U.S. commercial availability of …
Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025
GlobeNewswire
·
April 14, 2025
FRIENDSWOOD, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter …
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
GlobeNewswire
·
April 14, 2025
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-102 was well-tolerated with no treatment-related serious …
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer
GlobeNewswire
·
April 14, 2025
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie, 10 Barrel Brewing Co.’s highly-crushable new 5% IPA brewed in partnership with Scout Campers. …